Glycine is a major amino acid in mammals and other animals. It is synthesized from serine, threonine, choline, and hydroxyproline via inter-organ metabolism involving primarily the liver and kidneys. Under normal feeding conditions, glycine is not adequately synthesized in birds or in other animals, particularly in a diseased state. Glycine degradation occurs through three pathways: the glycine cleavage system (GCS), serine hydroxymethyltransferase, and conversion to glyoxylate by peroxisomal D-amino acid oxidase. Among these pathways, GCS is the major enzyme to initiate glycine degradation to form ammonia and CO2 in animals. In addition, glycine is utilized for the biosynthesis of glutathione, heme, creatine, nucleic acids, and uric acid. Furthermore, glycine is a significant component of bile acids secreted into the lumen of the small intestine that is necessary for the digestion of dietary fat and the absorption of long-chain fatty acids. Glycine plays an important role in metabolic regulation, anti-oxidative reactions, and neurological function. Thus, this nutrient has been used to: (1) prevent tissue injury; (2) enhance anti-oxidative capacity; (3) promote protein synthesis and wound healing; (4) improve immunity; and (5) treat metabolic disorders in obesity, diabetes, cardiovascular disease, ischemia-reperfusion injuries, cancers, and various inflammatory diseases. These multiple beneficial effects of glycine, coupled with its insufficient de novo synthesis, support the notion that it is a conditionally essential and also a functional amino acid for mammals (including pigs and humans).
Amino acids (AA) have enormous physiological importance, serving as building blocks for proteins and substrates for synthesis of low-molecular-weight substances. Based on growth or nitrogen balance, AA were traditionally classified as nutritionally essential or nonessential for animals. Although those AA that are not synthesized in eukaryotes (nutritionally essential AA, EAA) must be present in animal diets, nutritionally nonessential AA (NEAA) have long been ignored for all species. Emerging evidence shows that nonruminants cannot adequately synthesize NEAA or conditionally essential AA (CEAA) to realize their growth or anti-infection potential. Likewise, all preformed AA are needed for high-producing cows and rapidly growing ruminants. Many NEAA and CEAA (e.g., arginine, glutamine, glutamate, glycine, and proline) and certain EAA (e.g., leucine and tryptophan) participate in cell signaling, gene expression, and metabolic regulation. Thus, functions of AA beyond protein synthesis must be considered in dietary formulations to improve efficiency of nutrient use, growth, development, reproduction, lactation, and well-being in animals.
Pt single sites are highly attractive due to their high atom economy and can be generated on CeO2 by an oxidative high-temperature treatment. However, their location and activity are strongly debated. Furthermore, reaction-driven structural dynamics have not been addressed so far. Here, we were able to evidence Ptinduced CeO2 surface restructuring, locate Pt single sites on CeO2 and track the variation of the active state under reaction conditions using a complementary approach of density functional theory calculations, in situ infrared spectroscopy, operando high-energy-resolution fluorescence detected X-ray absorption spectroscopy and catalytic CO (as well as C3H6 and CH4) oxidation. We find that the onset of CO oxidation is linked to the migration of Pt single sites from four-fold hollow sites to form small clusters containing few Pt atoms. This demonstrates that operando studies on single sites are essential to assess their fate and the resulting catalytic properties. a promise as they lower the noble metal content significantly as all atoms are potentially active species. [5][6][7][8][9] Exploiting the strong noble metal support interaction between Pt and CeO2, metallic Pt particles can be formed orin contrast to weakly interacting supports like Al2O3redispersed, with tremendous impact on the catalyst activity. [10][11][12][13] The preparation of SAC has been demonstrated for Pt, which can be atomically dispersed when using CeO2 as a support through an oxidizing treatment at 800 °C. 14 However, the exact structure of the single sites, their reactivity and, particularly, their state and dynamics during reaction are still unknown and heavily debated. 4,15,16 The location of Pt single sites is claimed to range from surface adsorbates on {111} ceria steps, 17,18 {111}, 19 {110} 20,21 or {100} 6,22,23 ceria facets to surface 21,24,25 or bulk Ce substitutes [26][27][28] forming Ce1-XPt 2+ XO2-Y-composites. During change of the gas atmosphere and of the temperature, the structure of the single sites may strongly change resulting in a new and more active state. For example, after a high temperature treatment strong Pt-O-Ce bonds are reported to over-stabilize the single sites which are thus less active. 29 During the catalytic oxidation, oxygen is suggested to be provided by the support, while the reactant e.g. CO is adsorbed directly on Pt, 22,25 similar to Pt nanoparticles on CeO2. 30 Bera et al. correlated the intensity of the Pt-O-Ce bond observed by Extended X-ray Absorption Fine Structure (EXAFS) measurements with the catalytic activity for Ce1-XPt 2+ XO2-Y, 31 and Nie et al. 24demonstrated that the catalytic activation of a Pt single atom catalyst can be increased by steam treatment. It is suggested that this treatment leads to the formation of Ce1-XPt 2+ XO2-YH-OH species that are catalytically more active than Ce1-XPt 2+ XO2-Y. 24 In contrast, other studies report an increase in catalytic activity after a reductive treatment at temperatures below 300 °C. 9,32-34 Importantly, such
Analysis across the genome of patterns of DNA methylation reveals a rich landscape of allele-specific epigenetic modification and consequent effects on allele-specific gene expression.
Dietary supplementation of glutamine prevents intestinal dysfunction and atrophy in weanling piglets, but the underlying mechanism(s) are largely unknown. This study was conducted to test the hypothesis that weaning or glutamine may modulate expression of genes that are crucial for intestinal metabolism and function. In Expt. 1, we obtained small intestine from 28-d-old pigs weaned at 21 d of age and from age-matched suckling piglets. In Expt. 2, piglets were weaned at 21 d of age and then had free access to diets supplemented with 1% L-glutamine (wt:wt) or isonitrogenous L-alanine (control). At d 28, we collected small intestine for biochemical and morphological measurements and microarray analysis of gene expression using the Operon Porcine Genome Oligo set. Early weaning resulted in increased (52-346%) expression of genes related to oxidative stress and immune activation but decreased (35-77%) expression of genes related to macronutrient metabolism and cell proliferation in the gut. Dietary glutamine supplementation increased intestinal expression (120-124%) of genes that are necessary for cell growth and removal of oxidants, while reducing (34-75%) expression of genes that promote oxidative stress and immune activation. Functionally, the glutamine treatment enhanced intestinal oxidative-defense capacity (indicated by a 29% increase in glutathione concentration), prevented jejunal atrophy, and promoted small intestine growth (+12%) and body weight gain (+19%) in weaned piglets. These findings reveal coordinate alterations of gene expression in response to weaning and aid in providing molecular mechanisms for the beneficial effect of dietary glutamine supplementation to improve nutrition status in young mammals.
Background Alteration of the gut microbiota may contribute to the development of inflammatory bowel disease (IBD). Epigallocatechin-3-gallate (EGCG), a major bioactive constituent of green tea, is known to be beneficial in IBD alleviation. However, it is unclear whether the gut microbiota exerts an effect when EGCG attenuates IBD. Results We first explored the effect of oral or rectal EGCG delivery on the DSS-induced murine colitis. Our results revealed that anti-inflammatory effect and colonic barrier integrity were enhanced by oral, but not rectal, EGCG. We observed a distinct EGCG-mediated alteration in the gut microbiome by increasing Akkermansia abundance and butyrate production. Next, we demonstrated that the EGCG pre-supplementation induced similar beneficial outcomes to oral EGCG administration. Prophylactic EGCG attenuated colitis and significantly enriched short-chain fatty acids (SCFAs)-producing bacteria such as Akkermansia and SCFAs production in DSS-induced mice. To validate these discoveries, we performed fecal microbiota transplantation (FMT) and sterile fecal filtrate (SFF) to inoculate DSS-treated mice. Microbiota from EGCG-dosed mice alleviated the colitis over microbiota from control mice and SFF shown by superiorly anti-inflammatory effect and colonic barrier integrity, and also enriched bacteria such as Akkermansia and SCFAs. Collectively, the attenuation of colitis by oral EGCG suggests an intimate involvement of SCFAs-producing bacteria Akkermansia, and SCFAs, which was further demonstrated by prophylaxis and FMT. Conclusions This study provides the first data indicating that oral EGCG ameliorated the colonic inflammation in a gut microbiota-dependent manner. Our findings provide novel insights into EGCG-mediated remission of IBD and EGCG as a potential modulator for gut microbiota to prevent and treat IBD.
Efficiency of nutrient utilization is high in neonates with normal birth weights but is reduced in those with intrauterine growth restriction (IUGR). However, the underlying mechanisms are largely unknown. This study was conducted with the piglet model and proteomics technology to test the hypothesis that IUGR affects expression of key proteins that regulate growth and development of the small intestine, liver, and muscle, the major organs involved in the digestion, absorption, and metabolism of dietary nutrients. Jejunum, liver, and gastrocnemius muscle were obtained from IUGR and normal birth-weight piglets at birth for analysis of proteomes using the 2-dimensional-PAGE MS technology. The results indicate that IUGR decreased the levels of proteins that regulate immune function (immunoglobulins and annexin A1), oxidative defense (peroxiredoxin 1, transferrin, and zeta-crystallin), intermediary metabolism (creatine kinase, alcohol dehydrogenase, L-lactate dehydrogenase, prostaglandin F synthase, apolipoprotein AI, catecho O-methyltransferase, and phosphoglycerate kinase 1), protein synthesis (eukaryotic translation initiation factor-3), and tissue growth (beta-actin, desmin, and keratin 10) in a tissue-specific manner. In addition, IUGR increased the levels of proteins that are involved in proteolysis (proteasome alpha-5 and alpha-1 subunits), response to oxidative stress (scavenger-receptor protein and alpha-1 acid glycoprotein), and ATP hydrolysis (F1-ATPase). These novel findings suggest that cellular signaling defects, redox imbalance, reduced protein synthesis, and enhanced proteolysis may be the major mechanisms responsible for abnormal absorption and metabolism of nutrients, as well as reduced growth and impaired development of the small intestine, liver, and muscle in IUGR neonates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.